Sign Up Today and Learn More About HistoSonics Stock
Invest in or calculate the value of your shares in HistoSonics or other pre-IPO companies through EquityZen's platform.
HistoSonics Stock (HISO)
Developing a non-invasive, autonomous robotic platform capable of destroying tissue at a sub-cellular level
About HistoSonics Stock
Founded
2009
Headquarters
Ann Arbor, MI, US
Total Funding
86.1M
Industries
Health Care
HistoSonics, Inc. was created to advance the development of histotripsy, a science discovered and developed by leading scientists at the University of Michigan to provide improved therapies for patients. According to the company, its exclusive license to intellectual property, significant financial support, and strategic partnerships have helped HistoSonics develop Robotically Assisted Sonic Therapy (RAST)™, a novel beam therapy capable of destroying tissue at a sub-cellular level. HistoSonics’ team of specialists and industry leaders is based in Ann Arbor, Michigan.
HistoSonics Press Mentions
Stay in the know about the latest news on HistoSonics
Tech Visionaries Honored at Fast Company's New York City Gala
techtimes • Jun 17, 2025
HistoSonics and Cambridge University Unveil Europe’s First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift
businesswireindia • Jun 10, 2025
HistoSonics and Cambridge University Unveil Europe’s First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift
businesswire • Jun 10, 2025
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors
biospace • Jun 09, 2025
Other news to note for June 6, 2025
bioworld • Jun 09, 2025
HistoSonics Management
Leadership team at HistoSonics
VP of Regulatory & Clinical Affairs
Michael Daniel
CFO
Jon Freeman
Join now and verify your accreditation status to gain access to:
- HistoSonics Current Valuation
- HistoSonics Stock Price
- HistoSonics Management
- Available deals in HistoSonics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- HistoSonics Cap Table and Funding History by Share Class and Liquidity Preferences
- HistoSonics Revenue and Financials
- HistoSonics Highlights
- HistoSonics Business Model
- HistoSonics Risk Factors
- HistoSonics Research Report from SACRA Research
Trading HistoSonics Stock
How to invest in HistoSonics stock?
Accredited investors can buy pre-IPO stock in companies like HistoSonics through EquityZen funds. These investments are made available by existing HistoSonics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell HistoSonics stock?
Shareholders can sell their HistoSonics stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
